UK vets face price caps and transparency rules to curb rising costs

You feel as if all the interest is how much money they can squeeze from you.
A pet owner describes his experience after a vet quoted thousands for a rash that another clinic treated with steroids and antibiotics.
Mark

So the Competition and Markets Authority found that vet prices were rising twice as fast as inflation. That's a real problem. But now they're capping prescription fees at £21 and requiring price lists. Won't that help?

Mimi

It should, in theory. The idea is that transparency and price caps will let pet owners shop around and put pressure on vets to compete. And for people like Clive Di Giorgio, who was quoted thousands for what turned out to be a treatable rash, this kind of disclosure could be a real protection.

Luke

But here's the thing—the cap is only on the prescription fee itself, not on the drugs. And vets still have to maintain a fully stocked pharmacy. So if they can't make money on the drugs anymore, where does that pressure go?

Mimi

Right. Cate Titterton, an independent vet, said consultations and surgeries will likely have to go up. The margin has to come from somewhere.

Mark

So the rules might actually make things more expensive overall?

Luke

We don't know yet. But there's a real risk. And here's what worries the profession: the six firms that own two-thirds of all vet practices can absorb that kind of margin pressure. They have scale. Independent practices don't.

Mimi

The British Veterinary Association warned the CMA about this during the investigation. They said the remedies could hurt smaller practices disproportionately.

Mark

So we might end up with fewer, larger vet chains and fewer independent practices?

Luke

That's the fear. The rules are meant to help consumers, and they might. But they could also accelerate consolidation in a sector that's already dominated by six large groups. We won't know for a while.

Mimi

Vets have up to twelve months to implement everything. That's when we'll start to see what actually happens to prices and practice ownership.

  • Vet bills have been climbing at nearly double the inflation rate, leaving pet owners feeling squeezed between love for their animals and the cost of keeping them healthy.
  • The Competition and Markets Authority has now made its remedies legally binding, capping prescription fees at £21 and requiring itemised estimates for any treatment over £500.
  • Independent practices warn they will be forced to raise consultation and surgery fees to offset the profits they can no longer make on dispensed medicines.
  • Larger corporate groups — six of which already control more than two-thirds of UK practices — are positioned to absorb the pressure and may emerge stronger from the shake-up.
  • Pet owners will gain new tools to compare prices and challenge costs, but whether transparency alone can restore trust in a sector that feels increasingly profit-driven is an open question.

Britain's competition watchdog has imposed legally binding price controls and transparency requirements on the veterinary sector, after finding that animal care costs had been rising at nearly twice the rate of inflation. The measures — capping prescription fees, mandating written estimates, and requiring disclosure of cheaper drug alternatives — reflect a broader reckoning with what happens when a profession built on care becomes shaped by market consolidation. As with many regulatory interventions, the rules may protect consumers in one hand while quietly concentrating power in the other.

Britain's veterinary sector is now subject to legally binding rules designed to slow the rapid rise in animal care costs. The Competition and Markets Authority, after finding that vet prices had been climbing at nearly twice the rate of inflation, has given practices up to twelve months to comply with a sweeping set of changes.

At the heart of the overhaul is a £21 cap on prescription fees. Beyond that, practices must publish price lists for standard services, provide written itemised estimates before any treatment expected to exceed £500, and inform clients when cheaper versions of prescribed medicines are available online. They must also disclose whether they are independently owned or part of a corporate group — information that will feed into a national comparison service so pet owners can make more informed choices.

The CMA framed the measures as straightforward consumer protection. But the veterinary profession is not uniformly convinced. The British Veterinary Association had warned throughout the investigation that the rules risked falling hardest on smaller, independent practices — and those fears appear well founded. Independent owners like Cate Titterton of Saltburn explain that clinics depend on drug margins to sustain their pharmacies; if that income disappears, the cost must be recovered through higher fees for consultations and procedures. The likely beneficiaries, she argues, are the large corporate chains with the scale to absorb the pressure.

The human stakes were made vivid by Clive Di Giorgio, whose dog Louis was quoted thousands of pounds for cancer treatment — a diagnosis that a second vet dismissed entirely. Steroids and antibiotics resolved the problem within two weeks. His sense that financial interest had overtaken genuine care is precisely what the CMA's remedies aim to address. Whether they will restore that balance, or simply hasten the consolidation of veterinary care into fewer corporate hands, is the question the sector now faces.

Britain's veterinary practices are now operating under a new set of rules designed to rein in costs that have been climbing far faster than the broader economy. The Competition and Markets Authority, the country's official competition watchdog, made its remedies legally binding as of Tuesday, after an investigation revealed that vet prices had been rising at nearly twice the rate of inflation. Practices now have up to twelve months to bring all the changes into effect.

The centerpiece is a cap on prescription fees at £21. But the overhaul goes much further. Vets must now publish comprehensive price lists for standard services—consultations, common procedures, cremation options. For any treatment expected to cost £500 or more, they must provide a written estimate in advance, itemized and including aftercare costs. The only exception is emergencies. Practices must also disclose to clients whether cheaper versions of prescribed medicines are available online. And they must be transparent about their ownership structure, making clear whether they are independent or part of a larger corporate group. All of this information will flow into the Royal College of Veterinary Surgeons' "Find a Vet" service, which will share it with third-party comparison sites so pet owners can shop around.

Martin Coleman, the CMA panel chair overseeing the remedies, framed the changes as a straightforward consumer protection. "The changes that are being required are changes that will help inform pet owners about prices," he said. The watchdog's investigation had found a sector where prices were climbing unchecked, and the remedies were meant to create the kind of transparency and competitive pressure that might bring them back in line with the rest of the economy.

But the veterinary profession itself is divided on whether these rules will actually help. The British Veterinary Association's president, Dr. Rob Williams, noted that many practices were already doing much of what the CMA is now requiring—handling complaints properly, providing estimates for routine work, managing prescription costs responsibly. He said the association had pushed back on the CMA throughout its investigation, warning that the remedies could disproportionately hurt smaller, independent practices. That concern has proved prescient.

Cate Titterton, who owns an independent vet service in Saltburn, explained the bind her practice now faces. Veterinary clinics have to maintain a fully stocked pharmacy. If they can no longer make a profit on the drugs they dispense—because clients can now easily find cheaper versions online—they will have to recover that margin somewhere else. "Things like services, consultations, surgeries—unfortunately, those prices are very, very likely to have to go up," she said. She sees one clear winner in all this: the larger vet groups and corporate chains, which can absorb margin pressure across their portfolios and have the scale to negotiate better drug prices. The six firms that own more than two-thirds of all veterinary practices in Britain stand to benefit.

The human cost of the current system was captured in a story from Clive Di Giorgio, who contacted the BBC after his experience with his dog Louis. A vet quoted him thousands of pounds for treatment after diagnosing what he said was "definitely" cancer on Louis' back. Di Giorgio took his dog to a different surgery. That vet said the rash was not cancerous at all. A course of steroids, antibiotics, and a spray cleared it up in two weeks. "You just don't feel as if when you go to the vets now they're interested in the animal," Di Giorgio said. "You feel as if all the interest is how much money they can basically squeeze from you." It is precisely this kind of experience—the sense that cost, not care, has become the driving force—that the CMA's remedies are meant to address. Whether they will, or whether they will simply accelerate the consolidation of the sector into fewer, larger hands, remains to be seen.

Veterinary practices still have to have a pharmacy that is fully stocked, so if we're not making that tiny profit on the drugs, we're going to have to make some profit elsewhere. Things like services, consultations, surgeries—those prices are very, very likely to have to go up.
— Cate Titterton, independent vet practice owner
You just don't feel as if when you go to the vets now they're interested in the animal. You feel as if all the interest is how much money they can basically squeeze from you.
— Clive Di Giorgio, pet owner
Contact Us FAQ